tiprankstipranks
Trending News
More News >
Kontafarma China Holdings Ltd (HK:1312)
:1312
Hong Kong Market
Advertisement

Kontafarma China Holdings Ltd (1312) Price & Analysis

Compare
0 Followers

1312 Stock Chart & Stats


Kontafarma China Holdings Ltd News

1312 FAQ

What was Kontafarma China Holdings Ltd’s price range in the past 12 months?
Kontafarma China Holdings Ltd lowest stock price was HK$0.02 and its highest was HK$0.05 in the past 12 months.
    What is Kontafarma China Holdings Ltd’s market cap?
    Kontafarma China Holdings Ltd’s market cap is HK$156.20M.
      When is Kontafarma China Holdings Ltd’s upcoming earnings report date?
      Kontafarma China Holdings Ltd’s upcoming earnings report date is Mar 26, 2026 which is in 201 days.
        How were Kontafarma China Holdings Ltd’s earnings last quarter?
        Kontafarma China Holdings Ltd released its earnings results on Aug 28, 2025. The company reported -HK$0.051 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.051.
          Is Kontafarma China Holdings Ltd overvalued?
          According to Wall Street analysts Kontafarma China Holdings Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Kontafarma China Holdings Ltd pay dividends?
            Kontafarma China Holdings Ltd pays a Annually dividend of HK$0.004 which represents an annual dividend yield of N/A. See more information on Kontafarma China Holdings Ltd dividends here
              What is Kontafarma China Holdings Ltd’s EPS estimate?
              Kontafarma China Holdings Ltd’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Kontafarma China Holdings Ltd have?
              Kontafarma China Holdings Ltd has 5,588,572,000 shares outstanding.
                What happened to Kontafarma China Holdings Ltd’s price movement after its last earnings report?
                Kontafarma China Holdings Ltd reported an EPS of -HK$0.051 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                  Which hedge fund is a major shareholder of Kontafarma China Holdings Ltd?
                  Currently, no hedge funds are holding shares in HK:1312

                  Kontafarma China Holdings Ltd Stock Smart Score

                  5
                  Neutral
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Positive
                  20 days / 200 days
                  Momentum
                  -12.90%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  -41.48%
                  Trailing 12-Months
                  Asset Growth
                  -31.85%
                  Trailing 12-Months

                  Company Description

                  Kontafarma China Holdings Ltd

                  Kontafarma China Holdings Ltd. engages in the manufacture and sale of cement. It operates through the following segments: Pharmaceutical and Fitness Business. The Pharmaceutical Business segment involves in manufacture and sales of prescription drugs and laboratory related products. The Fitness Business segment includes the operation of fitness centers and provide consultation services for fitness and health activities and operate the franchise business for royalty fee income. The company was founded on March 21, 2011 and is headquartered in Hong Kong.

                  Kontafarma China Holdings Ltd (1312) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Extrawell Pharmaceutical Holdings Limited
                  China NT Pharma Group Co., Ltd.
                  PuraPharm Corp. Ltd.
                  Fusen Pharmaceutical Co., Ltd.
                  Huakang Biomedical Holdings Company Limited
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis